Skip to content

Drug interactions

Elvitegravir + Nicardipine

Severity: Minor

Elvitegravir and Nicardipine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elvitegravir is a CYP3A4 substrate, but it is given with cobicistat, a potent booster. Nicardipine's weaker CYP3A4 inhibition is unlikely to change elvitegravir exposure meaningfully, while cobicistat may raise nicardipine levels.

What this interaction means in plain words

Elvitegravir and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Nicardipine may weakly inhibit CYP3A4, but cobicistat's boosting dominates elvitegravir kinetics.

What to do

No elvitegravir adjustment is needed; monitor blood pressure and heart rate because cobicistat may raise nicardipine exposure.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir and Nicardipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir with Nicardipine?

MediHelp rates the interaction as minor. Elvitegravir and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elvitegravir is a CYP3A4 substrate, but it is given with cobicistat, a potent booster. Nicardipine's weaker CYP3A4 inhibition is unlikely to change elvitegravir exposure meaningfully, while cobicistat may raise nicardipine levels.

How serious is the interaction between Elvitegravir and Nicardipine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No elvitegravir adjustment is needed; monitor blood pressure and heart rate because cobicistat may raise nicardipine exposure.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in